| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/08/2007 | US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/08/2007 | US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214673 For therapy of psychosis and bipolar disorder |
| 05/08/2007 | CA2432138C New process for the preparation of eletriptan |
| 05/08/2007 | CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 05/03/2007 | WO2007051081A1 Methods and compounds for preparing cc-1065 analogs |
| 05/03/2007 | WO2007050522A1 Derivatives for modulation of ion channels |
| 05/03/2007 | WO2007049820A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | WO2007049293A1 An improved process for preparation of irbesartan |
| 05/03/2007 | WO2007049292A1 Pharmaceutical formulation of losartan |
| 05/03/2007 | WO2007049041A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007048767A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | WO2007048734A1 Use of 5-aminopyrazoles for controlling plant-pathogenic fungi, novel 5-aminopyrazoles, method for their production and agents containing said compounds |
| 05/03/2007 | WO2007048733A1 Use of 5-aminopyrazoles for controlling plant-pathogenic fungi, novel 5-aminopyrazoles, method for their production and agents containing said compounds |
| 05/03/2007 | WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them |
| 05/03/2007 | WO2007048361A1 A method of removing the triphenylmethane protecting group from precursors of antihypertensive drugs |
| 05/03/2007 | WO2007030848A3 Non-fluorescent chlorophyll catabolites |
| 05/03/2007 | WO2007027734A3 Bicyclic and bridged nitrogen heterocycles |
| 05/03/2007 | WO2007021711A3 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2007004041B1 New compounds and their pharmaceutical use |
| 05/03/2007 | WO2006127203A3 Methods of synthesizing 6-alkylaminoquinoline derivatives |
| 05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 05/03/2007 | US20070100141 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/03/2007 | US20070099976 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections |
| 05/03/2007 | US20070099974 (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |
| 05/03/2007 | US20070099973 Process for preparation of Irbesartan |
| 05/03/2007 | US20070099954 Prodrugs of compounds that inhibit TRPV1 receptor |
| 05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |
| 05/03/2007 | US20070099943 Quinazoline derivatives |
| 05/03/2007 | US20070099937 Substituted Pyrrolones As Allosteric Modulators of Glucokinase |
| 05/03/2007 | US20070099936 Dihydroisoindolones As Allosteric Modulators Of Glucokinase |
| 05/03/2007 | US20070099935 Azole-based kinase inhibitors |
| 05/03/2007 | US20070099934 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
| 05/03/2007 | US20070099930 Substituted Dihydroisoindolones As Allosteric Modulators of Glucokinase |
| 05/03/2007 | US20070099927 Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors |
| 05/03/2007 | US20070099924 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099920 Benzimidazoles useful as inhibitors of protein kinases |
| 05/03/2007 | US20070099917 Novel inhibitors and methods for their preparation |
| 05/03/2007 | US20070099916 nuclear hormone receptor inhibitors; to treat increased lipid levels, increased cholesterol levels, low HDL-cholesterol, high LDL-cholesterol, atherosclerotic diseases, diabetes, macular degeneration, Alzheimer's disease; 2-(1-benzyl-3-chloro-2-methyl-1H-indol-5-yl)-1,1,1,3,3,3-hexafluoro-propan-2-ol |
| 05/03/2007 | US20070099913 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099903 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/03/2007 | US20070099897 Therapeutic compounds |
| 05/03/2007 | US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099874 Methods and compositions of novel triazine compounds |
| 05/03/2007 | US20070099873 Quinolines useful as modulators of ion channels |
| 05/03/2007 | US20070099872 Functionally selective alpha2C adrenoreceptor agonists |
| 05/03/2007 | US20070099871 Bioreductively-activated prodrugs |
| 05/03/2007 | US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates |
| 05/03/2007 | US20070096639 Aromatic amine compound, and light emitting element, light emitting device, and electronic device using aromatic amine compound |
| 05/03/2007 | US20070096082 Crosslinkable arylamine compounds and conjugated oligomers or polymers based thereon |
| 05/03/2007 | US20070094814 Storage-stable fluorescent whitener formulations |
| 05/03/2007 | DE102005052127A1 Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New indol-containing beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE10148618B4 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments |
| 05/03/2007 | CA2627497A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | CA2627486A1 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2627046A1 Methods and compounds for preparing cc-1065 analogs |
| 05/03/2007 | CA2626375A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | CA2626190A1 Derivatives for modulation of ion channels |
| 05/03/2007 | CA2623360A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | CA2604404A1 An improved process for preparation of irbesartan |
| 05/02/2007 | EP1780208A1 Use of 5-amino pyrazoles for fighting plant pathogenic fungi, new 5-amino pyrazoles, method for their production and agents containing them |
| 05/02/2007 | EP1780206A1 Use of 5-amino pyrazoles for fighting plant pathogenic fungi, new 5-amino pyrazoles, method for their production and agents containing them |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779850A1 Tgf- gene expression inhibitor |
| 05/02/2007 | EP1778717A2 Cell adhesion inhibitors |
| 05/02/2007 | EP1778684A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR |
| 05/02/2007 | EP1778681A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 05/02/2007 | EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/02/2007 | EP1778676A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 05/02/2007 | EP1778675A1 Chiral pyrrolidine derivatives, and methods for preparing compounds thereof |
| 05/02/2007 | EP1778648A2 Compounds useful for inhibiting chk1 |
| 05/02/2007 | EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 05/02/2007 | EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 05/02/2007 | EP1778634A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/02/2007 | EP1778617A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |
| 05/02/2007 | EP1778242A2 Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 05/02/2007 | EP1778229A2 Amido compounds and their use as pharmaceuticals |
| 05/02/2007 | EP1778222A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 05/02/2007 | EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1546134B1 Piperazine substituted aryl benzodiazepines |
| 05/02/2007 | EP1537111B1 Hetereoaryl nitrile derivatives |
| 05/02/2007 | EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
| 05/02/2007 | EP1458707B1 New Indol-2-one derivatives |
| 05/02/2007 | EP1458685B1 Substituted phenyl derivatives |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1268478B1 Phenyl-substituted imidazopyridines |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | CN1956980A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956974A 2-substituted pyrimidines and their use as pesticides |